Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ASBP held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG | 191K | $197K | -92.4% | 12.810% | 0.00% |
| 2 | MORGAN STANLEY | 77K | $79K | β | 5.148% | 0.00% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 43K | $45K | -82.5% | 2.902% | 0.00% |
| 4 | Crewe Advisors LLC | 20K | $21K | -97.5% | 1.360% | 0.00% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 8K | $8K | β | 0.526% | 0.00% |
| 6 | Crossingbridge Advisors, LLC | 24K | $7K | 0.0% | 1.629% | 0.00% |
| 7 | TORONTO DOMINION BANK | 5K | $5K | β | 0.334% | 0.00% |
| 8 | VANGUARD FIDUCIARY TRUST CO | 3K | $3K | β | 0.191% | 0.00% |
| 9 | Tower Research Capital LLC (TRC) | 2K | $2K | -77.4% | 0.145% | 0.00% |
| 10 | CITIGROUP INC | 2K | $2K | β | 0.123% | 0.00% |
| 11 | HALLMARK CAPITAL MANAGEMENT INC | 1K | $1K | -97.5% | 0.067% | 0.00% |
| 12 | ADVISOR GROUP HOLDINGS, INC. | 2 | $2 | -98.0% | 0.000% | 0.00% |
| 13 | SBI Securities Co., Ltd. | 1 | $1 | β | 0.000% | 0.00% |
| 14 | Caitong International Asset Management Co., Ltd | 1 | $1 | β | 0.000% | 0.00% |
| 15 | Avion Wealth | 1K | $1 | -97.5% | 0.090% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in ASBP β a direct measure of their conviction.
Filings activity in ASBP during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new ASBP position in Q1 2026
Institutions that fully closed their ASBP position in Q1 2026
5 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 15 | 50% | 4.31% | 5.91 pp | $0M | 58% |
| Q4 2025 | 30 | +15% | 10.22% | +2.51 pp | $1M | +33% |
| Q3 2025 | 26 | +63% | 7.71% | +1.37 pp | $1M | +22% |
| Q2 2025 | 16 | +0.0% | 6.34% | 3.73 pp | $1M | 37% |
| Q1 2025 | 16 | β | 10.07% | β | $1M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ASBP stock.
Based on Q1 2026 13F filings, institutional ownership of Aspire Biopharma Holdings, Inc. stands at 4.3%, held across 15 reporting institutions.
UBS Group AG is the largest reported institutional holder of ASBP, with approximately 191,499 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of ASBP.
Our composite Smart Money Score for ASBP is 15 out of 100 (Heavy Distribution). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
7 institutions opened new positions in ASBP during Q1 2026, while 22 fully exited. 3 added to existing positions and 5 trimmed.
ASBP institutional ownership fell by 5.91 percentage points quarter-over-quarter, with a net change of -15 holders.
The top 10 institutions account for 99.7% of all reported 13F value in ASBP, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Aspire Biopharma Holdings, Inc. (ASBP) Institutional Ownership